Showing results (41-50 of 242) with videos related to
Sort By:
Pageof 25
American Journal of Medical Genetics|January 30, 1995
Paracentric inversion X(q21.2q24) associated with mental retardation in males and normal ovarian function in femalesD Abeliovich, J Dagan, C Kimchi-Sarfaty, et al.International Journal of Environmental Research and Public Health|December 3, 2014
A survey of African American physicians on the health effects of climate changeMona Sarfaty, Mark Mitchell, Brittany Bloodhart, et al.Plos Medicine|May 16, 2019
Limiting global warming to 1.5 to 2.0°C-A unique and necessary role for health professionalsEdward W Maibach, Mona Sarfaty, Mark Mitchell, et al.The Medical Journal of Australia|February 18, 1984
A pilot study of flutamide. A new agent in the treatment of advanced prostatic cancerG A Sarfaty, S J Alder, R G McLeanJournal of Urban Health : Bulletin of the New York Academy of Medicine|March 27, 2012
The effects of a group visit program on outcomes of diabetes care in an urban family practiceJeffrey A Reitz, Mona Sarfaty, James J Diamond, et al.Pharmacology, Biochemistry, and Behavior|February 1, 1989
The appetite suppressant, d-fenfluramine, decreases self-stimulation at a feeding site in the lateral hypothalamusR C McClelland, T Sarfaty, L Hernandez, et al.European Urology Open Science|September 11, 2023
Low Alanine Aminotransferase, as a Marker of Sarcopenia and Frailty, Is Associated with Shorter Survival Among Prostate Cancer Patients and Survivors. A Retrospective Cohort Analysis of 4064 PatientsMenachem Laufer, Maxim Perelman, Michal Sarfaty, et al.The Surgical Clinics of North America|November 10, 2024
Open Gastric Surgery for Gastric CancerAllen T Yu, Elad Sarfaty, Maranda Pahlkotter, et al.The Journal of Biological Chemistry|November 9, 2001
Transport activity and surface expression of the Na+-Ca2+ exchanger NCX1 are inhibited by the immunosuppressive agent cyclosporin A and by the nonimmunosuppressive agent PSC833Chava Kimchi-Sarfaty, Judith Kasir, Suresh V Ambudkar, et al.Cancers|January 11, 2024
Low Alanine Aminotransferase as a Marker for Sarcopenia and Frailty, Is Associated with Decreased Survival of Bladder Cancer Patients and Survivors-A Retrospective Data Analysis of 3075 PatientsMenachem Laufer, Maxim Perelman, Gad Segal, et al.Pageof 25